Precigen Inc (PGEN)
1.055
+0.04 (+4.46%)
USD |
NASDAQ |
Mar 31, 16:00
1.055
0.00 (0.00%)
After-Hours: 18:34
Precigen Price: 1.055 for March 31, 2023
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 30, 2023 | 1.01 | 1.06 | 0.9703 | 1.01 | 1.432M |
| Mar 29, 2023 | 0.92 | 1.08 | 0.8612 | 1.02 | 2.467M |
| Mar 28, 2023 | 0.8881 | 0.9424 | 0.8704 | 0.8836 | 1.474M |
| Mar 27, 2023 | 0.8245 | 0.90 | 0.805 | 0.8785 | 4.061M |
| Mar 24, 2023 | 0.97 | 0.97 | 0.9102 | 0.9601 | 1.809M |
| Mar 23, 2023 | 1.02 | 1.025 | 0.901 | 0.9372 | 3.952M |
| Mar 22, 2023 | 1.07 | 1.09 | 1.01 | 1.01 | 1.054M |
| Mar 21, 2023 | 1.01 | 1.09 | 1.01 | 1.09 | 1.272M |
| Mar 20, 2023 | 1.03 | 1.06 | 1.00 | 1.02 | 1.444M |
| Mar 17, 2023 | 1.08 | 1.08 | 1.00 | 1.02 | 4.999M |
| Mar 16, 2023 | 1.10 | 1.11 | 1.05 | 1.08 | 1.069M |
| Mar 15, 2023 | 1.10 | 1.12 | 1.05 | 1.10 | 1.143M |
| Mar 14, 2023 | 1.12 | 1.14 | 1.05 | 1.10 | 1.378M |
| Mar 13, 2023 | 1.11 | 1.12 | 1.05 | 1.09 | 1.534M |
| Mar 10, 2023 | 1.16 | 1.17 | 1.06 | 1.09 | 2.496M |
| Mar 09, 2023 | 1.30 | 1.31 | 1.16 | 1.17 | 1.533M |
| Mar 08, 2023 | 1.34 | 1.36 | 1.22 | 1.28 | 1.183M |
| Mar 07, 2023 | 1.18 | 1.40 | 1.18 | 1.35 | 2.970M |
| Mar 06, 2023 | 1.18 | 1.192 | 1.13 | 1.15 | 1.323M |
| Mar 03, 2023 | 1.18 | 1.18 | 1.11 | 1.16 | 1.155M |
| Mar 02, 2023 | 1.16 | 1.16 | 1.11 | 1.13 | 1.426M |
| Mar 01, 2023 | 1.25 | 1.275 | 1.14 | 1.15 | 3.470M |
| Feb 28, 2023 | 1.25 | 1.32 | 1.22 | 1.26 | 1.802M |
| Feb 27, 2023 | 1.22 | 1.275 | 1.20 | 1.26 | 1.560M |
| Feb 24, 2023 | 1.21 | 1.25 | 1.18 | 1.20 | 2.216M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.8785
Minimum
Mar 27 2023
19.87
Maximum
Apr 12 2018
6.077
Average
5.30
Median
Mar 26 2019
Price Benchmarks
| Sonoma Pharmaceuticals Inc | 0.982 |
| First Wave BioPharma Inc | 2.61 |
| Baudax Bio Inc | 1.685 |
| Xilio Therapeutics Inc | 3.10 |
| Abbott Laboratories | 101.26 |
Price Related Metrics
| PE Ratio | 7.536 |
| PS Ratio | 3.957 |
| Price to Book Value | 2.107 |
| Earnings Yield | 13.27% |
| Market Cap | 266.07M |